Argenx
ARGX
#505
Rank
NZ$81.35 B
Marketcap
NZ$1,311
Share price
0.44%
Change (1 day)
23.11%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company